PET/CT Dual Time Point Scanning in Evaluation of Malignant Lymphoma

Pitfalls in 18F-FDG PET/CT in Malignant Lymphoma.

Update of Assessment of Early Response Using PET/CT in Malignant Lymphoma.

Diagnostic Accuracy of Surveillance of FDG-PET/CT in Detection of Early Relapse in Malignant Lymphoma.

Role of Fluorine 18 Fluorodeoxy-Glucose (FDG) Positron Emission Tomography (PET)/ Computed Tomography (CT) in Evaluation of Lymphoma Patients

Role of 18F-FDG PET/CT in the Assessment of Extranodal Lesions in Patients with Lymphoma: An Observational Study

Factors Affecting the Metabolic Parameters Measured by 18F FDG PET/CT in Initial Assessment of Lymphoma Patients

The Comparative analysis of PET/CT and Contrast CT in the Evaluation of Patients with Lymphoma

COMPARISON OF 18F-FDG-PET/CT VERSUS WB DW-MRI IN STAGING AND EVALUATION OF RESPONSE FOR LYMPHOMA PATIENTS

Does Volumetric Metabolic PET/CT Parameters have impact in Prognosis in Pediatric Lymphoma patients.